Absci Corporation (ABSI): Pioneering AI-Driven Antibody Discovery with a ‘Buy’ Rating from Needham
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...
Benzinga.com3d
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Get Pro-Level Earnings Insights Before the Market Moves Needham analyst has initiated coverage on Absci Corporation ABSI, a drug and target discovery company that harnesses deep learning AI and ...
Investing4d
Needham initiates Absci shares with Buy rating on strategy
In other recent news, Absci Corp has been making significant strides in its AI-drug discovery sector. The company's earnings and revenue potential were highlighted by H.C. Wainwright, which ...
Top 10 Medical AI Stocks on Wall Street’s Radar
According to a 2023 PwC report, the AI market in healthcare was valued at $11 billion and is expected to grow to $188 billion by 2030. On January 21st, Oracle Co-founder Larry Ellison said during a ...
Investing3d
Needham initiates Absci shares with Buy rating on strategy
In other recent news, Absci Corp has been making significant strides in its AI-drug discovery sector. The company's earnings and revenue potential were highlighted by H.C. Wainwright, which reiterated ...
Small Cap Finds Mid-Week Success On Dual Announcement
Charting, Price Performance, News & Related Contracts.